GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST

TPE:3164 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
390.95401.23385.37318.02368.55427.93
Revenue Growth (YoY)
6.12%4.11%21.18%-13.71%-13.88%31.59%
Cost of Revenue
153.68149.6147.19106.82111.83128.6
Gross Profit
237.27251.63238.18211.19256.72299.33
Selling, General & Admin
145.01147.82152.79156.6137.12145.47
Research & Development
44.0645.3445.2746.8659.4125.52
Operating Expenses
196.4193.88197.55204.2194.75174.29
Operating Income
40.8657.7540.636.9961.97125.04
Interest Expense
-3.77-3.92-3.72-0.97-0.76-0.77
Interest & Investment Income
6.497.3911.69.464.82.35
Currency Exchange Gain (Loss)
-3-317.05-6.9810.45-1.35
Other Non Operating Income (Expenses)
3.971.440.40.34-1.981.06
EBT Excluding Unusual Items
44.5659.6765.978.8374.48126.34
Gain (Loss) on Sale of Investments
4.024.02-1.2319.05-8.169.35
Gain (Loss) on Sale of Assets
-0-0-0.020.28-0.063.74
Pretax Income
48.5863.6864.7228.1666.26139.42
Income Tax Expense
12.9715.716.975.7318.829.82
Earnings From Continuing Operations
35.647.9847.7522.4347.46109.6
Net Income to Company
35.647.9847.7522.4347.46109.6
Minority Interest in Earnings
9.299.229.510.569.523.53
Net Income
44.8957.257.2532.9956.98113.13
Net Income to Common
44.8957.257.2532.9956.98113.13
Net Income Growth
15.21%-0.09%73.53%-42.10%-49.64%85.82%
Shares Outstanding (Basic)
868687868686
Shares Outstanding (Diluted)
868787878787
Shares Change (YoY)
-0.83%-0.23%0.18%-0.10%-0.09%-1.50%
EPS (Basic)
0.520.660.660.380.661.31
EPS (Diluted)
0.520.660.660.380.661.30
EPS Growth
15.70%-73.68%-42.40%-49.25%88.41%
Free Cash Flow
54.0970.1979.891.2965.79-5.28
Free Cash Flow Per Share
0.630.810.920.010.76-0.06
Dividend Per Share
0.8000.8000.8000.5000.7001.100
Dividend Growth
--60.00%-28.57%-36.36%57.14%
Gross Margin
60.69%62.72%61.80%66.41%69.66%69.95%
Operating Margin
10.45%14.39%10.54%2.20%16.81%29.22%
Profit Margin
11.48%14.26%14.86%10.37%15.46%26.44%
Free Cash Flow Margin
13.84%17.49%20.73%0.41%17.85%-1.23%
EBITDA
103.59120.57108.1868.77109.92143.05
EBITDA Margin
26.50%30.05%28.07%21.63%29.82%33.43%
D&A For EBITDA
62.7362.8167.5561.7947.9518.02
EBIT
40.8657.7540.636.9961.97125.04
EBIT Margin
10.45%14.39%10.54%2.20%16.81%29.22%
Effective Tax Rate
26.71%24.65%26.22%20.35%28.37%21.39%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.